Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders characterized by chronic relapsing inflammation of the gastrointestinal tract that affect 0.1% of Western populations, comprising two major forms, Crohn\'s disease (CD) and ulcerative colitis (UC)[@b1]. In Crohn\'s disease the inflammation is often transmural, whereas in ulcerative colitis the inflammation is typically confined to the mucosa. Additionally, Crohn\'s disease can be associated with intestinal granulomas, strictures, and fistulas, but these are not typical findings in ulcerative colitis. Although our understanding of disease pathogenesis remains incomplete, accumulating evidence suggests that that IBD is a complex, multifactorial disease partly determined by a genetic predisposition[@b2]. Strong familial aggregation, twin studies, and established genetic associations[@b3][@b4][@b5]. indicate that there is a genetic component to the disease susceptibility in IBD. Recently, sequence variations associated with IBD have been reported for several genes, including NOD2, IL23R, IRGM, ATG16L1, PTPN2, and NK2 transcription factor related and locus 3 (NKX2-3)[@b6][@b7][@b8][@b9][@b10][@b11].

NKX2-3, located on 10q24, is a member of a family of genes that encodes transcription factors containing homeodomains and, therefore, is implicated in basic developmental functions. During development, NKX2-3 is expressed in midgut and hindgut mesoderm and spleen, as well as in pharyngeal endoderm[@b12][@b13]. The association between the NKX2-3 polymorphism and susceptibility of IBD was first reported in Caucasian patients[@b14]. After the first report of the association, several studies confirmed the association of tag-SNPs (rs10883365 and rs1190140) in the NKX2-3 gene with CD[@b15][@b16] as well as with UC in Caucasian or Asian populations[@b17][@b18][@b19]. However, several studies could not replicate the genetic association between IBD and NKX2-3 polymorphsims[@b15][@b20][@b21].

Thus, a quantitative synthesis may help to provide clearer evidence on the association of such genetic polymorphisms with IBD. In the present study, we conducted a meta-analysis of all eligible studies to quantitatively assess the associations between three common polymorphisms (rs10883365 and rs11190140) in the NKX2-3 gene and IBD susceptibility.

Results
=======

Characteristics of the included studies
---------------------------------------

The combined search yielded 75 references, of which 31 were duplicate studies, 9 were reviews, 4 were about cell studies, 8 were only with abstracts, 7 reported other mutations, 1 reported other disease. Finally, a total of 15 articles were finally included. Among them, one publication[@b15] contained data on two different subpopulations, one[@b16] included Wellcome Trust Case Control Consortium (WTCCC) samples and replication Crohn\'s disease (RCD) samples, and we treated them independently. In total, 17 studies comprising 17329 cases and 18029 controls were included in the present meta-analysis[@b11][@b15][@b16][@b17][@b18][@b19][@b20][@b21][@b22][@b23][@b24][@b25][@b26][@b27][@b28]. The 17 separate studies consisted of 13 European and 4 Asian. The distribution of genotypes in the control groups of all studies was in agreement with HWE except for 1 study[@b19]. Summaries of all included studies were summarized in [Table 1](#t1){ref-type="table"}, and the flow chart of study selection process was shown in [Figure 1](#f1){ref-type="fig"}.

Quantitative synthesis
----------------------

### Crohn\'s disease

The summary of meta-analysis for the NKX2-3 polymorphisms with CD is shown in [Table 2](#t2){ref-type="table"}, [Figure 2A](#f2){ref-type="fig"} and [Supplementary Figure S1](#s1){ref-type="supplementary-material"}. Regarding rs10883365 polymorphism, the results of combined analyses comprising 8699 cases and 13540 controls revealed a significantly increased risk of CD in all genetic models. In addition, the OR was 1.481 (1.351--1.623) in carriers of two risk G alleles compared with non-risk allele carriers (GG vs AA), which was higher than the risk of one G allele carriers (GA vs AA, OR = 1.141 (1.055--1.234), suggesting a dose--response with increasing number of the variant allele. In the subgroup analysis, significantly increased risks were found both among European and Asian population. No between-study significant heterogeneity was observed in all genetic models.

A total of 5484 patients and 4863 controls were investigated for rs11190140 variant, a significant association was found in all genetic models. (see [Supplementary Fig. S1](#s1){ref-type="supplementary-material"}) Similar to rs10883365, the OR (OR = 1.485, P \< 0.001) in carriers of 2 risk alleles was higher than that (OR = 1.155, P \< 0.001) in those of 1 risk allele. No between-study heterogeneity was detected in any genetic models of rs11190140 variant and CD risk.

### Ulcerative colitis

Seven studies with 4996 UC patients and 5479 controls for rs10883365 polymorphism were investigated. Meta-analysis findings of associations between rs10883365 in NKX2-3 gene and the risk of UC were shown in [Table 3](#t3){ref-type="table"} and [Figure 2B](#f2){ref-type="fig"}. Significantly increased UC risk was observed in all comparisons (G vs A: OR = 1.274 (1.175--1.382), GG vs AA: OR = 1.672 (1.474--1.896), GA vs AA = 1.207 (1.084--1.343), dominant model: OR = 1.342 (1.213--1.485), and recessive model: OR = 1.470 (1.325--1.630)). ([Fig. 2B](#f2){ref-type="fig"}) When stratified by ethnicity, significant association was found both in European and Asian subgroups except for one genetic model in Asian (GA vs AA: OR = 1.260 (0.971--1.634)). No heterogeneity was detected in major genetic models.

Sensitivity analyses and cumulative meta-analysis
-------------------------------------------------

Sensitivity analysis showed no single study qualitatively changed the pooled ORs. (see [Supplementary Fig. S2 and S3](#s1){ref-type="supplementary-material"}) Moreover, there was a study which deviated from HWE, when excluded, the estimated pooled OR still did not change at all, indicating that the results of this meta-analysis were high stable. ([Table 2](#t2){ref-type="table"} and [3](#t3){ref-type="table"}) In the cumulative meta-analysis, the pooled ORs tended to be stable and the associations tended toward significant associations with accumulation of more data over time between rs10883365 or rs11190140 variant and CD risk, as well as between rs10883365 and UC risk (see [Fig. 3](#f3){ref-type="fig"} and [Supplementary Fig. S4](#s1){ref-type="supplementary-material"}).

Publication bias
----------------

Funnel plots and Egger\'s test were performed to assess publication bias. No publication bias was detected for rs10883365 polymorphism. (G vs A: t = −0.04, p = 0.966 and t = 1.56, p = 0.181 in CD and UC, respectively). Similarly, no publication bias was detected for T vs C contrast of rs11190140 polymorphism in CD. (see [Supplementary Fig. S6](#s1){ref-type="supplementary-material"}) As shown in [Supplementary Figure S5](#s1){ref-type="supplementary-material"}, the shapes of the funnel plots did not indicate any evidence of obvious asymmetry for rs10883365 variant and CD or UC risk.

Discussion
==========

Presently the mechanisms of the etiology and progression of IBD are far from clear. Several genes have been identified to be associated with IBD risk, including NOD2, NKX2-3 and IL-23. Recently, genome-wide association studies (GWAS) have identified SNPs implicating hundreds of replicated loci for common traits and becomes a powerful tool to detect the susceptibility genes in the IBD diseases[@b16][@b29][@b30]. Several GWAS and GWAS meta-analysis have provided strong evidences for the association between NKX2-3 single nucleotide polymorphisms (SNPs) (rs6584283 and rs4409764) and risk of IBDs[@b31][@b32][@b33]. However, two common variants (rs10883365 and rs11190140) in NKX2-3 gene were not included in the GWAS meta-analyses.

A meta-analysis can combine results from individual studies to overcome the limitation of small sample sizes and inadequate statistical power, and produce a single estimate of the major effect. Recently, accumulated meta-analysis has been performed to investigate the association of genetic variants with susceptibility to CD or UC. Polymorphisms in several genes, including ATG16L1 T300A[@b34], TGF-α G308A[@b35], MIF G173C[@b36], OCTN1 C1672T[@b37], CD14 C260T[@b38] and MDR1 C3435T[@b39], were identified as risk factors of CD or UC. Patients with mutant allele of NOD1 rs6958571[@b40] and Pro12Ala[@b41] might have a decreased susceptibility to IBD. Additionally, some genetic variants were not association with CD or UC risk, such as MDR1 C1236T[@b39], IL-10 G1082A[@b42], and IL-18 A607C[@b43]. Therefore, we saw the need to perform pooled analyses with larger sample size by summarizing previous case--control or cohort studies in order to better understand the association between the NKX2-3 variants and IBD risk.

NKX2-3, located on chromosome 10q24, is predominantly expressed in mesoderm of midgut and hindgut during embryonic mouse development[@b12]. Postnatally, Nkx2-3 expression continues in gut mesenchyme and in spleen. In addition, mice lacking Nkx2-3 exhibit severe defects in gut development; primarily in the epithelium of the small intestine[@b44]. The perturbations of the gut tissue architecture lead to early postnatal death presumably due to digestive malfunctions. Moreover, analysis of Nkx2-3-deficient mice has revealed a critical role for NKX2-3 in spleen development and in establishing the correct environment for normal B cell development and T cell dependent immune response[@b45][@b46]. Recently, associations between the two common polymorphisms (rs10883365 and rs11190140) in NKX2-3 gene and susceptibility of CD or UC have been reported in several studies.

To the best of our knowledge, the present study involving 37039 subjects represents the first comprehensive meta-analysis investigating the association between NKX2-3 polymorphisms (rs10883365 and rs11190140) and IBD susceptibility. For the analysis of rs10883365 polymorphism, a significantly increased CD risk was observed in all genetic models. In the ethnicity-stratified analyses, significant association was found both in Asian and European populations. Similar results were found between the rs11190140 variant and risk of CD where a significant association was found European population (no Asian population reported). No between-study heterogeneity was observed in most genetic models. Sensitivity analysis indicated that when excluding studies departed from HWE, the pooled OR still did not change, demonstrating the results of this meta-analysis were stable. Since these two SNPs are close to each other, we use 1000 Genomes Pilot sequence data to identify whether these SNPs are in linkage disequilibrium (LD) (r^2^ \> 0.8). The results indicated that rs10883365 and rs11190140 are in perfect LD (r^2^ = 1.0).

CD and UC, as two major subtypes of IBD, are believed to share overlapping but distinct clinical and pathological features, and have great differences in genetic backgrounds[@b11]. Some genes, such as NOD2 and ATG16L1, were associated with CD, but not with UC[@b47][@b48]. However, recent GWAS meta-analysis identified 163 IBD loci that meet genome-wide significance thresholds, 50 of these have an indistinguishable effect size in UC and CD, including IL23R (rs11209026), IL10 (rs3024505) and MST1 (rs3197999). In the present meta-analysis, significant association between rs10883365 and risk of UC was found in all genetic models. When stratified by ethnicity, similar correlation was observed both in Asians and Europeans. No between-study heterogeneity existed in major genetic models. Sensitivity analysis showed no single study qualitatively changed the pooled ORs. Moreover, excluding studies departed from HWE, the pooled OR still did not change, demonstrating the results of this meta-analysis were stable. These results indicated that rs10883365 polymorphism in NKX2-3 gene may be significantly associated with both CD and UC.

By combining the data of individual studies, we increased the statistical power to detect subtle associations, however,several limitations should be considered in our meta-analysis. Only studies published in the English and Chinese language were included in this meta-analysis; therefore, publication bias may have occurred. In addition, this meta-analysis was designed to analyze single polymorphism, a haplotype analysis may have been more powerful for finding significant associations with UC and CD. Finally, gene--environment interactions were not analyzed because of insufficient data.

Despite these limitations, our results still yield statistical results. Taken together, we expand previously individual studies on IBD by suggesting that NKX2-3 gene rs10883365 polymorphisms might contribute to the occurrence of both CD and UC, and suggested that persons with a T allele of rs1190140 variant might have a significantly increased risk of CD. Further studies or large case-control studies, especially studies emphasizing genotype--phenotype interaction should be performed to clarify possible roles of NKX2-3in IBD. Moreover, studies involved in NKX2-3 polymorphisms in different populations with larger sample size might need to be performed.

Methods
=======

Search strategy
---------------

We searched PubMed and Embase to identify genetic association studies of the rs10883365 or rs11190140 polymorphism and IBD risks. Electronic searches were performed by using the following search terms: 'Inflammatory Bowel Disease\' or 'IBD\', 'Crohn\'s disease\' or 'CD\', 'ulcerative colitis\' or 'UC\', 'NKX2-3\', 'rs10883365\', or 'rs11190140\', (the last search update was 1 September 2013). In addition, the reference lists of reviews and retrieved articles were checked by hand-search for additional potential studies. A study reported results from more than one population was considered as separate studies.

Inclusion and exclusion criteria
--------------------------------

Studies were considered eligible if they had to meet the following criteria: (1) association between NKX2-3 polymorphisms and risk of IBD (CD or UC), (2) case-control or cohort studies. Studies were excluded for the following reasons: (1) articles only with an abstract and review articles (2) no control population, (3) studies considered overlapped with other studies.

Data extraction
---------------

Two authors extracted the following data independently from each of the eligible articles: first author, publication year, ethnicity of the participants involved (categorized as Europeans or Asians), number of cases and controls, information (age, mean age at diagnosis and sex) of cases and controls, and number of genotypes or allele frequency in cases and controls. Study authors were contacted for detailed data when there was insufficient information to determine the relationship between genetic polymorphism and IBD risk. Disagreements were resolved by discussion between the two authors.

Statistical analysis
--------------------

Pooled odds ratios (ORs) and 95% confidence intervals (CIs) used to assess the strength of the association between IBD risk (CD or UC) and NKX2-3 polymorphisms (rs10883365 or rs11190140). The significance of the pooled OR was determined by the Z-test; a P-value of \<0.05 was considered significant. The Hardy-Weinberg equilibrium (HWE) in the control group was assessed, and a P \< 0.05 was considered as significant disequilibrium. For rs10883365 polymorphism, the pooled ORs were estimated for G versus A, GG versus AA, GA versus AA, dominant model (GG + GA versus AA), and recessive model (GG versus GA + AA). Because of only three studies[@b19][@b49][@b50] available for the association between rs11190140 variant and UC risk, we have performed meta-analysis of correlation between rs11190140 polymorphism and CD risk. Subgroup analysis was performed according to ethnicity.

Between-study heterogeneity was evaluated by using the Chi-square based Q test and I2 test[@b51]. Heterogeneity was considered significant for P \< 0.10, and a random-effects model was used, otherwise, fixed-effects model was used. In addition, if heterogeneity was detected, Galbraith plots were used to visualize the impact of individual studies on the overall homogeneity, which spot the outliers as the possible major sources of heterogeneity[@b52][@b53]. Moreover, a meta-regression was used to delineate the major sources of between-study heterogeneity[@b54].

Sensitivity analysis was carried out to evaluate the stability of the results after sequential removal of each study or by excluding those studies deviated from HWE. In addition, cumulative meta-analyses were carried out for each polymorphism through assortment of studies with publication time. Graphical evaluation of funnel plots and Egger\'s linear regression test were performed to assess publication bias[@b55]. If significant publication bias was detected, ORs and 95% CI would be adjusted by trim and fill methods[@b56]. All statistical analyses were performed by STATA software, version 12 (StataCorp LP, College Station, Texas).
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![OR estimates with the corresponding 95% CI for the association between rs10883365 polymorphism in NKX2-3 gene and CD or UC risk.\
(a): rs10883365 polymorphism and CD risk (G vs. A), (b): rs10883365 polymorphism and UC risk (G vs. A). The sizes of the squares reflect the weighting of included studies. OR: odds ratio; CI: confidence interval.](srep03924-f2){#f2}

![Cumulative meta-analysis on the association between rs10883365 polymorphism and CD or UC risk.\
(a): rs10883365 variant and CD risk (G vs. A); (b): rs10883365 variant and UC risk (G vs. A). Pooled OR estimates with the 95% CI as information accumulates at the end of each year (left column). CD: Crohn\'s disease; UC: ulcerative colitis; OR: odds ratio; CI: confidence interval.](srep03924-f3){#f3}

###### Main Characteristics of Studies Involved in NKX2-3 polymorphism and Crohn\'s disease or ulcerative colitis Risk

                                             Cases                 Controls                                                                                                                   
  --------------------- ----------- ----------------------- ---------------------- ------------------ ---------- ---------------------------------------------- ------ ------ --------------- -------------
  Tanaka, 2009            Asians          rs10883365              CD and UC             CD: 174        CD: 65.5                    CD: 16--61                    394    48.0      19--76           nr
                                                                  separately            UC: 296        UC: 48.0                    UC: 15--79                                                        
  Meggyesi, 2010         Europeans        rs10883365         CD and UC separately       CD: 810        CD: 53.6   CD: 37.1 ± 12.6 and 26.5 ± 10.6 at diagnosis   469    53.5    40.5 ± 11.5    Age and sex
  Meggyesi, 2010         Europeans        rs10883365         CD and UC separately       UC: 428        UC: 47.2   UC: 43.7 ± 15.0 and 31.3 ± 13.4 at diagnosis                                       
  Fisher, 2008           Europeans        rs10883365                  UC                UC: 1841          nr                           nr                        1470    nr         nr             nr
  Franke, 2008           Europeans   rs10883365 rs11190140   CD and UC separately   CD: 1850UC: 1103   CD: 32.0          CD: mean 38 and 21at diagnosis          1817    nr         nr         Age and sex
  Parkes, 2007           Europeans        rs10883365                  CD                CD: 1182       CD: 40.3       CD: mean 43.9 and 25.5 at diagnosis        2024    nr         nr             nr
  Parkes, 2007           Europeans        rs10883365                  CD                CD: 1748       CD: 39.2       CD: mean 45.7 and 26.1 at diagnosis        5740    nr         nr             nr
  Yu, 2009               Europeans        rs10883365                  CD                 CD: 75           nr                           nr                        255     nr         nr             nr
  Yamazaki, 2009          Asians          rs10883365                  CD                CD: 484        CD: 72.8          CD: 22.4 (7--55) at diagnosis           470    50.2   38.7(21--77)          
  Pang, 2010              Asians          rs10883365                  CD                 CD: 66        CD: 48.5                CD: 36.26 ± 11.82                  66    50.0   35.42 ± 13.14   Age and sex
  Arai, 2011              Asians          rs10883365         CD and UC separately    CD: 344UC: 253      nrnr                         nrnr                       243     nr         nr             nr
  Weersma, 2009          Europeans        rs10883365         CD and UC separately   CD: 1656UC: 1075      nr                           nr                        1086    nr         nr             nr
  van der Heide, 2010    Europeans        rs10883365                  CD                CD: 310          34.5           CD:26.6 (7.5--73.9) at diagnosis         976     nr         nr             nr
  Latiano, 2011          Europeans        rs11190140                  CD                CD: 1070       CD: 56%                         nr                        783     nr         nr             nr
  Laukens, 2010          Europeans        rs11190140                  CD                CD: 1051          nr                           nr                        676     nr         nr             nr
  Peter, 2011            Europeans        rs11190140                  CD                CD: 369           nr                           nr                        503     nr         nr             nr
  Waterman, 2011         Europeans        rs11190140                  CD                CD: 1144       CD: 53%             CD: 16(2--62) at diagnosis            1057   36%         nr             nr
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NKX2-3: NK2 transcription factor related and locus 3; CD: Crohn\'s disease, UC: ulcerative colitis, nr: not report.

###### Pooled analysis for the associations between the polymorphism of NKX2-3 and the risk of Crohn\'s disease

  Variant        Comparison        Variables      No. of   Sample Size   Test of association          Model           Test of heterogeneity             
  ------------ --------------- ----------------- -------- ------------- --------------------- ---------------------- ----------------------- --- ------ -------
  rs10883365       G vs A           Overall         12        8699              13540          1.226 (1.177--1.277)          \<0.001          F   0.0    0.968
                                  All in HWE        9         4883              9661           1.215 (1.154--1.280)          \<0.001          F   0.0    0.913
                                   European         8         7631              12367          1.226 (1.174--1.280)          \<0.001          F   0.0    0.944
                                     Asian          4         1068              1173           1.223 (1.082--1.382)           0.001           F   0.0    0.613
                  GG vs AA          overall         10        6733              11478          1.481 (1.351--1.623)          \<0.001          F   0.0    0.936
                                  All in HWE        9         4883              9661           1.476 (1.328--1.639)          \<0.001          F   0.0    0.893
                                   European         6         5665              10305          1.481 (1.342--1.635)          \<0.001          F   0.0    0.905
                                     Asian          4         1068              1173           1.477 (1.148--1.901)           0.002           F   0.0    0.566
                  GA vs AA          Overall         10        6733              11478          1.141 (1.055--1.234)           0.001           F   0.0    0.836
                                  All in HWE        9         4883              9661           1.159 (1.059--1.268)           0.001           F   0.0    0.807
                                   European         6         5665              10305          1.116 (1.024--1.215)           0.012           F   0.0    0.796
                                     Asian          4         1068              1173           1.280 (1.055--1.553)           0.012           F   0.0    0.807
                GG + GA vs AA       Overall         10        6733              11478          1.241 (1.153--1.336)          \<0.001          F   0.0    0.887
                                  All in HWE        9         4883              9661           1.254 (1.152--1.365)          \<0.001          F   0.0    0.846
                                   European         6         5665              10305          1.225 (1.130--1.328)          \<0.001          F   0.0    0.814
                                     Asian          4         1068              1173           1.328 (1.106--1.595)           0.002           F   0.0    0.693
                GG vs GA + GA       Overall         10        6733              11478          1.362 (1.263--1.468)          \<0.001          F   0.0    0.960
                                  All in HWE        9         4883              9661           1.345 (1.235--1.465)          \<0.001          F   0.0    0.948
                                   European         6         5665              10305          1.373 (1.268--1.486)          \<0.001          F   0.0    0.927
                                     Asian          4         1068              1173           1.297 (1.024--1.598)           0.030           F   0.0    0.710
  rs11190140       T vs C       Over(Europeans)     5         5484              4836           1.201 (1.136--1.269)          \<0.001          F   0.0    0.773
                                  All in HWE        2         2121              1426           1.190 (1.080--1.311)          \<0.001          F   0.0    0.544
                  TT vs CC      Over(Europeans)     3         3971              3276           1.485 (1.297--1.700)          \<0.001          F   0.0    0.631
                                  All in HWE        2         2121              1426           1.412 (1.162--1.716)           0.001           F   0.0    0.516
                  TC vs CC      Over(Europeans)     3         3971              3276           1.155 (1.029--1.298)           0.015           F   0.0    0.478
                                  All in HWE        2         2121              1426           1.227 (1.033--1.458)           0.020           F   0.0    0.430
                TT + TC vs CC   Over(Europeans)     3         3971              3276           1.253 (1.122--1.398)          \<0.001          F   0.0    0.867
                                  All in HWE        2         2121              1426           1.289 (1.095--1.516)           0.002           F   0.0    0.785
                TT vs TC + CC   Over(Europeans)     3         3971              3276           1.344 (1.204--1.501)          \<0.001          F   50.1   0.135
                                  All in HWE        2         2121              1426           1.239 (1.061--1.446)           0.007           F   45.4   0.176
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NKX2-3: NK2 transcription factor related and locus 3; R: Random-effects model, F: fixed-effects model, HWE: Hardy-Weinberg equilibrium; OR: odds ratio; CI: confidence interval.

###### Pooled analysis for the associations between the polymorphism of NKX2-3 and the risk of ulcerative colitis

  Variant        Comparison     Variables    No. of   Sample Size   Test of association          Model           Test of heterogeneity             
  ------------ --------------- ------------ -------- ------------- --------------------- ---------------------- ----------------------- --- ------ -------
  rs10883365       G vs A        Overall       7         4996              5479           1.274 (1.175--1.382)          \<0.001          R   44.5   0.094
                                All in HWE     5         2818              2576           1.268 (1.174--1.369)          \<0.001          F   36.5   0.178
                                Europeans      5         4447              4842           1.225 (1.156--1.298)          \<0.001          F   41.1   0.147
                                  Asians       2          549               637           1.452 (1.232--1.712)          \<0.001          F   0.0    0.176
                  GG vs AA       overall       6         3921              4393           1.672 (1.474--1.896)          \<0.001          F   20.1   0.282
                                All in HWE     5         2818              2576           1.619 (1.387--1.889)          \<0.001          F   30.5   0.218
                                Europeans      4         3372              3756           1.609 (1.404--1.844)          \<0.001          F   26.0   0.255
                                  Asians       2          549               637           2.078 (1.500--2.878)          \<0.001          F   0.0    0.654
                  GA vs AA       Overall       6         3921              4393           1.207 (1.084--1.343)           0.001           F   0.0    0.901
                                All in HWE     5         2818              2576           1.242 (1.090--1.416)           0.001           F   0.0    0.905
                                Europeans      4         3372              3756           1.196 (1.063--1.345)           0.003           F   0.0    0.814
                                  Asians       2          549               637           1.260 (0.971--1.634)           0.082           F   0.0    0.466
                GG + GA vs AA    Overall       6         3921              4393           1.342 (1.213--1.485)          \<0.001          F   0.0    0.801
                                All in HWE     5         2818              2576           1.356 (1.199--1.533)          \<0.001          F   0.0    0.688
                                Europeans      4         3372              3756           1.317 (1.179--1.472)          \<0.001          F   0.0    0.767
                                  Asians       2          549               637           1.467 (1.151--1.869)           0.002           F   0.0    0.454
                GG vs GA + GA    Overall       6         3921              4393           1.470 (1.325--1.630)          \<0.001          F   43.9   0.112
                                All in HWE     5         2818              2576           1.391 (1.223--1.581)          \<0.001          F   41.2   0.146
                                Europeans      4         3372              3756           1.455 (1.202--1.761)          \<0.001          R   53.9   0.089
                                  Asians       2          549               637           1.534 (1.160--2.028)          \<0.001          F   0.0    0.894
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NKX2-3: NK2 transcription factor related and locus 3; R: Random-effects model, F: fixed-effects model, HWE: Hardy-Weinberg equilibrium; OR: odds ratio; CI: confidence interval.
